INTRODUCTION {#sec1-1}
============

Transfusion-related acute lung injury, also known as TRALI, is a rare, underreported but serious complication of blood transfusion. Interaction of specific leukocyte antibodies from the donor with the leukocytes of the recipient causes noncardiogenic pulmonary edema indistinguishable from adult respiratory distress syndrome (ARDS). The diagnosis is usually made on clinical grounds as a diagnosis of exclusion although demonstration of antileukocyte antibody in donor or rarely in the recipient can be helpful.

CASE REPORT {#sec1-2}
===========

A 39-year-old female patient of American Society of Anesthesiologists (ASA) grade 2 was presented for total abdominal hysterectomy. She was a known diabetic and hypertensive, well controlled with insulin and Angiotensin Converting Enzyme (ACE) inhibitors. Systemic examination was clinically normal. Blood counts, urea, creatinine, electrocardiograph, and chest X-ray were all normal, except for mild anemia (hemoglobin 9.8%).

Following overnight fasting, she received oral antihypertensive, i.v. antibiotic, and i.m. pethidine and promethazine.

Surgery was performed under general anesthesia. Airway maneuvers were smooth and recovery uneventful; 1000 ml crystalloid was infused intraoperatively.

For the next 24 h, patient was hemodynamically stable with good urine output.

Because hemoglobin was 8.4 g% and PCV (Packed Cell Volume) 27%, whole blood transfusion was advised on the second postoperative day. After approximately 250ml of blood had been transfused, patient developed chills, fever, and tachycardia. Blood pressure was 150/90 mmHg.

Patient became tachypneic, dyspneic, and SpO~2~ was 89% on room air. Diffuse bilateral crepitations were present.

Transfusion was discontinued and remaining blood was found to be compatible when re-crossmatched. The donor was the patient\'s brother and the whole blood did not undergo leukodepletion. Patient received O~2~ by face mask, along with bronchodilators, steroids, and diuretics. There was no oliguria or hemoglobinuria. Overnight patient maintained 95% saturation with 10 l/min O~2~ by face mask.

Patient showed persistent tachycardia and tachypnea on the third postoperative day. Blood counts, urea, creatinine, and electrocardiograph were normal.

Chest X-ray showed bilateral nonhomogenous opacities but no cardiomegaly \[[Figure 1](#F1){ref-type="fig"}\]. Echocardiogram showed mild RA/RV dilatation possibly due to acute lung injury (ALI).
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ABG (Arterial Blood Gas) revealed pH 7.45, pO~2~ 81 mmHg, SpO~2~ 96%, pCO~2~ 32 mmHg, and BE --3.0 at 10 l/min flow of oxygen via face mask.

After sedation and paralysis, she was intubated and ventilated on controlled mode using FiO~2~ 1, PEEP 10 cm H~2~O resulting in a saturation of 100%. Bronchodilator, steroid, and antibiotic therapy were continued.

A clinical diagnosis of ALI, probably transfusion related, was made after excluding other causes (vide infra, see DISCUSSION).

On the fourth postoperative day, significant improvement occurred clinically, radiologically, and on ABG, hence weaning was initiated.

Patient was successfully extubated on the sixth postoperative day and O~2~ was continued via face mask \[[Figure 2](#F2){ref-type="fig"}\].
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She was maintaining saturation on room air and was shifted to the ward on the seventh postoperative day.

DISCUSSION {#sec1-3}
==========

The term TRALI was coined by Popovsky *et al*.\[[@ref1]\] in 1983 referring to noncardiogenic pulmonary edema complicating transfusion. Popovsky also published the first and largest series of TRALI cases in 1985.\[[@ref2]\] In 1951, Barnard described the first case of fatal pulmonary edema accompanying transfusion therapy.\[[@ref3]\]

The incidence is 1 in 5000 units transfused and up to 1 in 625 transfused patients,\[[@ref4]\] probably due to underreporting. The 5--8% mortality rate in TRALI cases distinguishes it from ARDS which has a mortality rate of 30--50%.\[[@ref5]\]

Canadian consensus panel defines TRALI as a new episode of ALI occurring during or within 6 h of a transfusion, not temporally related to another risk factor for ALI.\[[@ref6]\] ALI implies acute hypoxemia demonstrated by a PaO~2~/FiO~2~ ratio of \<300; SpO~2~ \<90% on room air; bilateral infiltrates on chest radiograph; and no evidence of left atrial hypertension. If ALI is due to other causes but still temporally related to transfusion, then TRALI is still a possibility.\[[@ref7]\]

TRALI is associated with transfusion of whole blood, FFP (Fresh Frozen Plasma), platelets, cryoprecipitate, immunoglobulin, and stem cell preparations. Directed donation from mother to child, or mother to father may present a higher risk due to sensitization of the mother to paternal antigen of the fetus during pregnancy;\[[@ref4]\] 10--15% incidence of TRALI has been seen in unleukodepleted blood transfusion.

Mechanism is immunologically mediated wherein; WBC (Whole Blood Corpuscles) antibodies were identified in donor serum as part of a transfusion reaction evaluation following TRALI.\[[@ref8]\] These react with patients' granulocytes and HLA (Human Leukocyte Antigens) class I and class II antigens. Rarely WBC antibodies in recipient can also cause TRALI.\[[@ref9]\]

Nonimmune mechanism has also been described where interleukin-6 lipid activation is possible when TRALI occurs without antileukocyte antibodies.\[[@ref10]\]

It is postulated that the HLA antibodies may cause the following sequence of events to occur to produce lung injury: (1) antibodies bind to and directly activate neutrophils; (2) complement is activated resulting in the production of anaphylatoxins that promote neutrophil aggregation and sequestration in the pulmonary microvasculature; (3) neutrophils marginate into the pulmonary vasculature and release enzymes, cytokines (tumor necrosis factor-alpha, interleukin-1, 6, and 8), and superoxide radicals that damage the blood vessels; and (4) endothelial cell injury occurs resulting in pulmonary edema due to the accumulation of protein and fluid due to capillary leakage. Autopsy findings in a patient who died of TRALI substantiate this mechanism.\[[@ref11]--[@ref13]\] Other predisposing factors (general anesthesia, infection, recent surgery, exogenous cytokines, and massive transfusions) have been suggested.\[[@ref8]\]

The diagnosis of TRALI is essentially clinical by exclusion, further supported by demonstration of matching leukocyte antibodies in donor serum and increased neutrophil priming activity in the transfused blood.

Management of TRALI is mainly supportive. Oxygen and ventilatory support appropriate for the degree of hypoxia and fluid administration for hypotension. Steroids and diuretics have no definite role.

In general, most cases show improvement within the first few hours and completely resolve within 24--96 h.

Several approaches to the prevention of TRALI have been recommended. Among these recommendations are (1) limit the amount of plasma transfused from implicated donors by transfusing either washed or frozen-deglycerolized red blood cells; (2) indefinitely defer donors implicated in fatal TRALI; (3) defer multiparous women as donors; (4) screen donor units for leukoagglutinins; (5) change manufacturing processes to limit accumulation of lipids during storage; and (6) identify patients at risk for TRALI and use washed or fresh components for them.\[[@ref12][@ref13]\] The listed preventive measures are potentially expensive and challenging to supply necessary products in a timely manner.

TRALI has been recognized as a discrete clinical entity since the early 1980s. However, many clinicians remain unaware of the condition because TRALI must be differentiated from a number of other conditions including ARDS, pneumonia, cardiac failure, circulatory overload, bacterial contamination, and acute hemolytic transfusion reaction. Differentiation may be difficult and is a diagnosis of exclusion based on clinical signs and symptoms rather than laboratory testing. TRALI should be considered when a recently transfused patient develops acute respiratory distress.\[[@ref14]--[@ref16]\]

The possibility of TRALI in our case was the final diagnosis after ruling out the following differential causes.

Cardiogenic pulmonary edema was ruled out because there were no signs of fluid overload preoperatively and no cardiomegaly on X-ray. The RA/RV dilation on ECHO could have been due to hypoxic pulmonary vasoconstriction.

As the desaturation was acute, blood counts were normal, and antibiotics were given preoperatively, we ruled out the possibility of a lung infection.

Aspiration pneumonia was excluded as patient was fasting; the intubation/extubation procedures were uneventful, and resolution was rapid and complete.

Sepsis from the transfusion could also be ruled out as the blood counts were normal; there was no multiorgan involvement and the resolution was rapid.

The clinical setting did not support a possibility of anaphylaxis and could be ruled out when the blood was re-crossmatched.

Based on the clinical setting and response to treatment, TRALI was the probable diagnosis in our case after excluding the above differential diagnoses.

**Source of Support:** Nil

**Conflict of Interest:** None declared.
